3-trifluoromethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine (also known as Sitagliptin Triazole Impurity) is an intermediate in the synthesis of Sitagliptin,which is an oral antihyperglycemic (antidiabetic drug) of the dipeptidyl peptidase-4 (DPP4) inhibitor class. This drug was developed and marketed by Merck & Co. for the treatment of diabetes mellitus type2.
NONH for all modes of transport
1. Product Specification
2. Safety Data Sheet
Please inquire for pricing and availability of this product by writing email firstname.lastname@example.org.